PTC Therapeutics Recovers From An Ugly Fall After European Officials Reject DMD Drug

PTC stock rose Friday after European regulators voted to withdraw the biotech company's treatment for a severe form of muscular dystrophy. The post PTC Therapeutics Recovers From An Ugly Fall After European Officials Reject DMD Drug appeared first on Investor's Business Daily.
Source: Reuters: Health - Category: Consumer Health News Source Type: news